Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6890738

Prolactin antagonists and uses thereof

The Regents of the University of California · Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6878709

3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists

Pharmacopeia Drug Discovery, Inc. · Granted Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872728

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849429

Viral pseudo-capsids including assembly agonists and antagonists

The Board of Regents of the University of Texas System · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6846799

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6811780

Methods of using cytokine antagonists to treat HIV infection and AIDS

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756038

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750350

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6747034

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6740656

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue May 25 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723721

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6692741

Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

The Regents of the University of California · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693202

Muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6677340

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673796

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630124

Combination therapy with VIP antagonist

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620825

Adenosine A3 receptor antagonists

Takeda Chemical Industries Ltd. · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620802

Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor ant

Corcept Therapeutics Incorporated · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608197

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6589547

Sustained-release preparation for AII antagonist, production and use thereof

Takeda Chemical Industries Ltd. · Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6586413

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583143

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569431

Recombinant antibody fragments as autoantibody antagonists

The Regents of the University of California · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566324

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired